Literature DB >> 28124010

Comments on "NAFLD causes selective CD4+ T lymphocyte loss and promotes hepatocarcinogenesis".

Guangbing Li1, Li Yuan2, Jun Liu1, Haitao Zhao3.   

Abstract

Entities:  

Year:  2016        PMID： 28124010      PMCID： PMC5218916          DOI： 10.21037/hbsn.2016.12.02

Source DB:  PubMed          Journal:  Hepatobiliary Surg Nutr        ISSN： 2304-3881            Impact factor:   7.293


× No keyword cloud information.
  11 in total

1.  From NAFLD to NASH to fibrosis to HCC: role of dendritic cell populations in the liver.

Authors:  Frank Tacke; Hiroyuki Yoneyama
Journal:  Hepatology       Date:  2013-06-25       Impact factor: 17.425

Review 2.  From NAFLD to NASH and HCC: pathogenetic mechanisms and therapeutic insights.

Authors:  Samuele De Minicis; Chris Day; Gianluca Svegliati-Baroni
Journal:  Curr Pharm Des       Date:  2013       Impact factor: 3.116

3.  Lipid metabolism signatures in NASH-associated HCC.--letter.

Authors:  Sonja M Kessler; Stephan Laggai; Ahmad Barghash; Volkhard Helms; Alexandra K Kiemer
Journal:  Cancer Res       Date:  2014-04-28       Impact factor: 12.701

Review 4.  Hepatocarcinogenesis and ceramide/cholesterol metabolism.

Authors:  Albert Morales; Montserrat Mari; Carmen Garcia-Ruiz; Anna Colell; Jose C Fernandez-Checa
Journal:  Anticancer Agents Med Chem       Date:  2012-05       Impact factor: 2.505

5.  Increased Oxidative Stress and RUNX3 Hypermethylation in Patients with Hepatitis B Virus-Associated Hepatocellular Carcinoma (HCC) and Induction of RUNX3 Hypermethylation by Reactive Oxygen Species in HCC Cells.

Authors:  Poonsin Poungpairoj; Patcharawalai Whongsiri; Surasit Suwannasin; Apichaya Khlaiphuengsin; Pisit Tangkijvanich; Chanchai Boonla
Journal:  Asian Pac J Cancer Prev       Date:  2015

6.  Mitochondrial cholesterol contributes to chemotherapy resistance in hepatocellular carcinoma.

Authors:  Joan Montero; Albert Morales; Laura Llacuna; Josep M Lluis; Oihana Terrones; Gorka Basañez; Bruno Antonsson; Jesús Prieto; Carmen García-Ruiz; Anna Colell; José C Fernández-Checa
Journal:  Cancer Res       Date:  2008-07-01       Impact factor: 12.701

Review 7.  Innate immune response and hepatic inflammation.

Authors:  Gyongyi Szabo; Pranoti Mandrekar; Angela Dolganiuc
Journal:  Semin Liver Dis       Date:  2007-11       Impact factor: 6.115

Review 8.  Regulation of metabolism by the innate immune system.

Authors:  Denise E Lackey; Jerrold M Olefsky
Journal:  Nat Rev Endocrinol       Date:  2015-11-10       Impact factor: 43.330

9.  Characterization of hepatocellular carcinoma (HCC) in non-alcoholic fatty liver disease (NAFLD) patients without cirrhosis.

Authors:  Bashar Mohamad; Vaishal Shah; Mykola Onyshchenko; Mohammed Elshamy; Federico Aucejo; Rocio Lopez; Ibrahim A Hanouneh; Razan Alhaddad; Naim Alkhouri
Journal:  Hepatol Int       Date:  2015-11-11       Impact factor: 6.047

10.  NAFLD as a risk factor for HCC: new rules of engagement?

Authors:  Ryota Masuzaki; Seth J Karp; Masao Omata
Journal:  Hepatol Int       Date:  2016-05-05       Impact factor: 6.047
View more
  2 in total

Review 1.  Reshaping the systemic tumor immune environment (STIE) and tumor immune microenvironment (TIME) to enhance immunotherapy efficacy in solid tumors.

Authors:  Liangliang Xu; Chang Zou; Shanshan Zhang; Timothy Shun Man Chu; Yan Zhang; Weiwei Chen; Caining Zhao; Li Yang; Zhiyuan Xu; Shaowei Dong; Hao Yu; Bo Li; Xinyuan Guan; Yuzhu Hou; Feng-Ming Kong
Journal:  J Hematol Oncol       Date:  2022-07-07       Impact factor: 23.168

2.  Organ-specific cholesterol metabolic aberration fuels liver metastasis of colorectal cancer.

Authors:  Kai-Li Zhang; Wen-Wei Zhu; Sheng-Hao Wang; Chao Gao; Jun-Jie Pan; Zun-Guo Du; Lu Lu; Hu-Liang Jia; Qiong-Zhu Dong; Jin-Hong Chen; Ming Lu; Lun-Xiu Qin
Journal:  Theranostics       Date:  2021-04-27       Impact factor: 11.556
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.